Identification of autoantibodies expressed in acquired aplastic anaemia

British Journal of Haematology

Volumn 160, Issue 3, 2013, Pages 359-362

  Goto, Maki ^a   Kuribayashi, Kageaki ^a,b   Takahashi, Yusuke ^a,b   Kondoh, Takashi ^a,b   Tanaka, Maki ^a,b   Kobayashi, Daisuke ^a,b   Watanabe, Naoki ^a,b  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aplastic anaemia; Autoantibody; Ribosomal protein; SEREX; Serological marker

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACQUIRED APLASTIC ANEMIA; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT COMPLEMENTARY DNA EXPRESSION CLONING; STROMA CELL; TARGET CELL;

ANEMIA, APLASTIC; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHLORIDE CHANNELS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; K562 CELLS; METALLOPROTEINS; NUCLEAR PROTEINS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS;

EID: 84872560698     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12116     Document Type: Article

References (15)

1. Ades, L., Mary, J.Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E. & Socie, G. (2004) Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood, 103, 2490-2497.
2. Chen, J. (2005) Animal models for acquired bone marrow failure syndromes. Clinical Medicine and Research, 3, 102-108.
3. Coombs, R.R.A. & Lachmann, P.J. (eds) (1975) Classification of Allergic Reactions Responsible for Clinical Hypersensitivity and Disease. Blackwell, Oxford, UK.
4. Dokal, I. & Vulliamy, T. (2010) Inherited bone marrow failure syndromes. Haematologica, 95, 1236-1240.
5. Feng, X., Chuhjo, T., Sugimori, C., Kotani, T., Lu, X., Takami, A., Takamatsu, H., Yamazaki, H. & Nakao, S. (2004) Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood, 104, 2425-2431.
6. Gannage, M. & Munz, C. (2009) Autophagy in MHC class II presentation of endogenous antigens. Current Topics in Microbiology and Immunology, 335, 123-140.
7. Hirano, N., Butler, M.O., Von Bergwelt-Baildon, M.S., Maecker, B., Schultze, J.L., O'Connor, K.C., Schur, P.H., Kojima, S., Guinan, E.C. & Nadler, L.M. (2003) Autoantibodies frequently detected in patients with aplastic anemia. Blood, 102, 4567-4575.
8. Hirano, N., Butler, M.O., Guinan, E.C., Nadler, L.M. & Kojima, S. (2005) Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients. British Journal of Haematology, 128, 221-223.
9. Kobayashi, R., Yabe, H., Hara, J., Morimoto, A., Tsuchida, M., Mugishima, H., Ohara, A., Tsukimoto, I., Kato, K., Kigasawa, H., Tabuchi, K., Nakahata, T., Ohga, S. & Kojima, S. (2006) Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. British Journal of Haematology, 135, 693-696.
10. McGowan, K.A., Pang, W.W., Bhardwaj, R., Perez, M.G., Pluvinage, J.V., Glader, B.E., Malek, R., Mendrysa, S.M., Weissman, I.L., Park, C.Y. & Barsh, G.S. (2011) Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood, 118, 3622-3633.
11. Qi, Z., Takamatsu, H., Espinoza, J.L., Lu, X., Sugimori, N., Yamazaki, H., Okawa, K. & Nakao, S. (2010) Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia. Annals of Hematology, 89, 1255-1263.
12. Risitano, A.M. (2010) Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. British Journal of Haematology, 152, 127-140.
13. Shapiro-Shelef, M. & Calame, K. (2005) Regulation of plasma-cell development. Nature Reviews Immunology, 5, 230-242.
14. Takamatsu, H., Feng, X., Chuhjo, T., Lu, X., Sugimori, C., Okawa, K., Yamamoto, M., Iseki, S. & Nakao, S. (2007) Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia. Blood, 109, 2514-2520.
15. Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 2509-2519.